Acta Derm Venereol

1. LI L, Chen Y, Lin M, Hou L, et al
   Real-world Efficacy and Safety of Stapokibart in Children and Adolescents with Moderate-to-severe Atopic Dermatitis: A Retrospective Study.
   Acta Derm Venereol. 2026;106:0258.
   

   >> Share

   
   

   
   Allergy

2. HAYASHI A, Kakiyama S, Kawano K, Harima-Mizusawa N, et al
   Fecal Lipid Metabolites and Microbiota Alterations in Dogs With Concurrent Atopic Dermatitis and Adverse Food Reaction.
   Allergy. 2026 May 11. doi: 10.1111/all.70370.
   

   >> Share

   
   

   
   Am J Respir Crit Care Med

3. CHUPP G, Nagase H, Skowasch D, Devouassoux G, et al
   Switching to twice-yearly depemokimab from mepolizumab/benralizumab in severe asthma: A multicenter, randomized, double-blind, Phase 3A Clinical Trial (NIMBLE).
   Am J Respir Crit Care Med. 2026 Feb 11:aamag031. doi: 10.1093.
   

   >> Share

   
   

   
   Ann Allergy Asthma Immunol

4. NGUYEN K, Nicolas LM, Haber C, Al-Shaikhly T, et al
   Racial and Ethnic Differences in Subcutaneous Allergen Immunotherapy Prescription for Children with Allergic Rhinitis.
   Ann Allergy Asthma Immunol. 2026 May 12:S1081-1206(26)00201.
   

   >> Share

   
   
5. SZE ST, Leung D, Nguyen AA, Chamseddine S, et al
   Rapid Drug Desensitization in Pediatric Patients: A Multicenter Study.
   Ann Allergy Asthma Immunol. 2026 May 11:S1081-1206(26)00199.
   

   >> Share

   
   
6. LANZ MJ, Cespedes LH, Chartrand EM, Eisenlohr CP, et al
   Utility of Exhaled Nitric Oxide as a Potential Biomarker in Non-Asthmatics with Multiple Food Allergies.
   Ann Allergy Asthma Immunol. 2026 May 11:S1081-1206(26)00196.
   

   >> Share

   
   
7. FINEMAN SM, Joshi SR, Chow T, Knox SM, et al
   From the pages of AllergyWatch.
   Ann Allergy Asthma Immunol. 2026;136:616-617.
   

   >> Share

   
   
8. COYLE L, McDowell PJ, Heaney LG
   Lessons learned regarding optimal use of biologics to achieve disease remission in severe asthma.
   Ann Allergy Asthma Immunol. 2026 Feb 28:S1081-1206(26)00069.
   

   >> Share

   
   
9. KHARBANDA S, Stocker L, Rupani H
   Asthma in pregnancy: optimising treatment strategies and the emerging role of biologic therapies.
   Ann Allergy Asthma Immunol. 2026 Feb 28:S1081-1206(26)00071.
   

   >> Share

   
   
10. LUGOGO NL, Han JK, Peters AT, Lee SE, et al
    Tezepelumab's effects on patient-reported symptoms in severe asthma, overall and with history of comorbid CRSwNP.
    Ann Allergy Asthma Immunol. 2026 Feb 13:S1081-1206(26)00057.
    

    >> Share

    
    
11. SUTER P, Greig R, Lipworth BJ
    Bucher indirect treatment comparison of phase 3 trials with dupilumab and tezepelumab in chronic rhinosinusitis with nasal polyps.
    Ann Allergy Asthma Immunol. 2026;136:589-595.
    

    >> Share

    
    
12. LIPWORTH B, Zambelli E, Agazzi R, Piraino A, et al
    Relative particle size and distribution of inhaled triple therapies.
    Ann Allergy Asthma Immunol. 2026;136:545-549.
    

    >> Share

    
    
13. LEE Y, Chang JH, Kim C, Lee E, et al
    Clustering of patients with severe asthma based on long-term FEV1% changes: Real-world evidence.
    Ann Allergy Asthma Immunol. 2025 Dec 5:S1081-1206(25)01371.
    

    >> Share

    
    
14. GOCEBE D, Ries L, Schakel K
    Novel 4-day outpatient Hymenoptera venom immunotherapy buildup protocol with low reaction rates.
    Ann Allergy Asthma Immunol. 2026;136:550-557.
    

    >> Share

    
    

    
    Arch Pediatr

15. AGGOUN ZIOUECHE N, Grimaud E, Lemale J, Lemoine A, et al
    Pediatric Eosinophilic Esophagitis Symptom Score (PEESS) in the management of eosinophilic esophagitis in children: A narrative review of the literature.
    Arch Pediatr. 2026;33:105482.
    

    >> Share

    
    

    
    BMC Pediatr

16. TSUGE M, Uda K, Ikeda M, Tsukahara H, et al
    Sebastidae-specific food allergy causing anaphylaxis: a pediatric case report and fish allergen analysis.
    BMC Pediatr. 2026 May 14. doi: 10.1186/s12887-026-06987.
    

    >> Share

    
    

    
    Chest

17. LI PY, Gershon A, Kouri A
    Evaluating the Accuracy of Large Language Models in Answering Asthma Multiple Choice and Objective Structured Clinical Examination Questions.
    Chest. 2025 Dec 8:S0012-3692(25)05816-7. doi: 10.1016/j.chest.2025.
    

    >> Share

    
    
18. MATHIAS KR, Mustafa AM, Nyakinye KJ, Wotoroson V, et al
    TEAM Sarcoidosis: Creating a Multidisciplinary Care Team for Complex Clinical Management.
    Chest. 2026;169:1279-1285.
    

    >> Share

    
    
19. HARPER LJ, Baughman RP, Lower EE, Bonella F, et al
    Incidence of New Comorbidities After Steroid Use in Patients With Sarcoidosis: An International Cross-Sectional Survey.
    Chest. 2026;169:1267-1278.
    

    >> Share

    
    
20. YADAV CP, Lim LHM, Price D, Roy R, et al
    Interactive Pathways of Key Prognostic Factors in Severe Asthma: A Bayesian Network Comparison of Clinical Trials & Real-World Data.
    Chest. 2026 Jan 24:S0012-3692(26)00125-X. doi: 10.1016/j.chest.2026.
    

    >> Share

    
    

    
    Contact Dermatitis

21. ROUYER N, Charansol A, Hanniet A, Aubin F, et al
    Airborne Contact Allergy to Ebony Wood With Photo-Aggravation.
    Contact Dermatitis. 2026 May 12. doi: 10.1111/cod.70182.
    

    >> Share

    
    

    
    Int Arch Allergy Immunol

22. ASLAN SAVAS S, Colkesen F, Gerek ME, Sagun F, et al
    Psychological Symptom Burden After Anaphylaxis in Adults: A Cross-Sectional Study.
    Int Arch Allergy Immunol. 2026 May 11:1-16. doi: 10.1159/000552435.
    

    >> Share

    
    
23. SENDAL M, Caliskan N, Ozceker D
    Pediatric Allergic Contact Dermatitis: Sensitization Patterns for a Practical Panel.
    Int Arch Allergy Immunol. 2026 May 11:1-11. doi: 10.1159/000552351.
    

    >> Share

    
    

    
    J Am Acad Dermatol

24. RAO S, Patin E, Santiago Mangual KP, Murase JE, et al
    Unraveling the Strands of Inequality: Disparities in Low-Allergy Risk Alternatives for High Hair Curl Index Hair.
    J Am Acad Dermatol. 2026 May 13:S0190-9622(26)02647.
    

    >> Share

    
    
25. HAGINO T, Saeki H, Fujimoto E, Kanda N, et al
    Long-term outcomes after switching from baricitinib 4 mg to upadacitinib 30 mg in atopic dermatitis: a 144-week retrospective study.
    J Am Acad Dermatol. 2026 May 13:S0190-9622(26)02648.
    

    >> Share

    
    
26. YANG Y, Xu B, Zhang K, Qing Y, et al
    IL-36A axis suppression associates with clinical response to stapokibart in head and neck atopic dermatitis-An exploratory proteomic study.
    J Am Acad Dermatol. 2026 May 7:S0190-9622(26)00555.
    

    >> Share

    
    

    
    J Invest Dermatol

27. YEUNG K, Weber JF, Stegenborg-Grathwohl SM, Hu T, et al
    Anakinra alters epidermal tissue-resident memory T cell profiles but fails to reduce clinical responses upon nickel re-challenge in individuals with nickel allergy.
    J Invest Dermatol. 2026 May 8:S0022-202X(26)01190.
    

    >> Share

    
    
28. CHEN R, Miltner LA, Loman L, Schuttelaar MLA, et al
    ADULTS WITH ATOPIC DERMATITIS AND ATOPIC MULTIMORBIDITY EXPERIENCE IMPAIRED SLEEP QUALITY.
    J Invest Dermatol. 2026 May 7:S0022-202X(26)01188.
    

    >> Share

    
    

    
    PLoS One

29. KAWAI H, Sarai M, Kato Y, Naruse H, et al
    Association of 18F-fluorodeoxyglucose uptake with cardiac events in cardiac sarcoidosis during outpatient follow-up after immunosuppression.
    PLoS One. 2026;21:e0347595.
    

    >> Share

    
    
30. LEE TY, Petkau J, Johnson KM, Turvey SE, et al
    Development of an asthma policy model for Canada: Lifetime Exposures and Asthma outcomes Projection.
    PLoS One. 2026;21:e0348878.
    

    >> Share

    
    
31. SHI C, Wang Y, Tan C, Zeng X, et al
    Cost-effectiveness analysis of mepolizumab among patients with severe asthma from the Chinese societal perspective.
    PLoS One. 2026;21:e0348955.
    

    >> Share

    
    
32. CHOI SI, Jeong Y, Jung WJ, Kim BK, et al
    Usefulness of lung sound data collection using Skeeper SM-300(R) device: A pilot study.
    PLoS One. 2026;21:e0348588.
    

    >> Share

    
    
33. SU S, Lin Y
    Identification of a diagnostic metabolomic fingerprint in plasma for eosinophilic granulomatosis with polyangiitis.
    PLoS One. 2026;21:e0343182.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share